Terms: = Bone cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Prognosis
5 results:
1. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of IDH mutations in chondrosarcoma.
Nakagawa M; Sekimizu M; Endo M; Kobayashi E; Iwata S; Fukushima S; Yoshida A; Kitabayashi I; Ichikawa H; Kawai A; Nakatani F
J Orthop Sci; 2022 Nov; 27(6):1315-1322. PubMed ID: 34531086
[TBL] [Abstract] [Full Text] [Related]
3. Giant cell tumor of bone - Analysis of 213 cases involving extra-craniofacial bones.
Konishi E; Outani H; Mano M; Nagata S; Shirai T; Naka N; Hori Y; Takenaka S; Haga H; Toguchida J; Kakunaga S; Kuwae Y; Hoshi M; Inoue T; Aono M; Morinaga Y; Nakashima Y
Pathol Int; 2021 Aug; 71(8):500-511. PubMed ID: 34125982
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract] [Full Text] [Related]
5. [Malignant maxillary tumors involving the pterygo-maxillary and infratemporal fossae: a series of 200 cases].
Cantù G; Solero C; Mattavelli F; Pizzi N; Valentini V; Santamaria S; Barberi F; Riccio S
Acta Otorhinolaryngol Ital; 2000 Apr; 20(2):91-9. PubMed ID: 10992601
[TBL] [Abstract] [Full Text] [Related]
